loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2006_054___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Inke S.A

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Inke, S.A. Castellbisbal ES (1)

    filter

    01 Risperidone (1)

    filter

    01 Spain (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Inke, S.A. Castellbisbal ES

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Risperidone

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF CN
    R1-CEP 2006-054 - Rev 00
    Valid
    Chemical
    2012-07-16
    1559
    Inke Company Banner

    RDD 2024

    Exhibiting

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-054 - Rev 00 of Inke, S.a. Castellbisbal Es

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-054 - Rev 00 of Inke, S.a. Castellbisbal Es 1

    20

    Inke, S.a. Castellbisbal Es, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Inke S.A: APIs manufacturing plant.

    One of their significant offerings is Risperidone, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-054 - Rev 00

    This Chemical Type CEP, issued on July 16, 2012, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1559 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY